Guidance Document: Part C, Division 5 of the Food and Drug Regulations “Drugs for Clinical Trials Involving Human Subjects” (GUI-0100)

Written by Barbara Brown



Health Canada | N2 News



August 27, 2019

Health Canada has released their new guidance document for clinical trial researchers to comply with Part C, Div 5 of the Food & Drug Regulations. Review the document here.

Updates to Canada’s Strategy for Patient Oriented Research (SPOR)

Oct 3, 2024

We are delighted to share a new report on behalf of Canada’s Strategy for Patient Oriented Research (SPOR),...

N2 Cultural Competency Skills in Clinical Research Course now available!

Oct 2, 2024

This course is now part of the N2 base membership, which means all N2 members will receive it as part of their...

National Day for Truth and Reconciliation

Sep 30, 2024

Today we observe Truth and Reconciliation. At N2, we acknowledge the lasting effects of Canada's colonial history on...